Lead and cadmium are toxic heavy metals that have been shown to be possible risk factors of atherosclerosis in epidemiological and experimental studies. Since excess extracellular matrix, including proteoglycans, accumulates changing the composition and the structure in the atherosclerotic vascular wall, the effects of lead and cadmium on the proteoglycan synthesis in vascular cells have been studied using a cell culture system. The following results were obtained: Lead does not destroy endothelial cell layers but markedly inhibits the repair of the injured cell layers, which results from a lower response to endogenous basic fibroblast growth factor caused by inhibition of the synthesis of perlecan, a large heparan sulfate proteoglycan, in vascular endothelial cells. Lead selectively inhibits the synthesis of versican, a large chondroitin sulfate proteoglycan, in vascular smooth muscle cells only at a high cell density. Cadmium induces the synthesis of biglycan and decorin, small dermatan sulfate proteoglycans, in vascular smooth muscle cells only at a low cell density, while inhibiting the synthesis of other proteoglycan molecules. It is therefore suggested that lead and cadmium may influence the developmental process of atherosclerosis through disrupting the regulation of proteoglycan synthesis in vascular cells.
INTRODUCTION
Atherosclerosis is a vascular lesion which is hypothesized to be initiated by dysfunction and injury of vascular endothelial cells followed by hyperplasia of vascular smooth muscle cells in the intima of vascular wall by a complicated mechanism. 1) Thus, the repair of damaged vascular endothelium without delay is important for prevention of atherosclerosis. Basic fibroblast growth factor (FGF-2) is crucially involved in endothelial repair through promotion of cell growth and migration in an autocrine fashion; the growth factor is leaked from severely damaged or dead endothelial cells and stimulates the cell proliferation near the damaged site.
2) Heparin or heparan sulfate chains are required for both binding of FGF-2 to its cell surface receptor and exhibition of the biologic activites. 3, 4) The glycosaminoglycans (GAGs) directly form the FGF-2 and FGF-receptor complexes and consequently the receptor dimmers; the ternary complex formation transduces the receptor tyrosine-kinase activation. 5) However, regulation of vascular endothelial cell proliferation by changes in GAG metabolism has been only incompletely understood.
Proteoglycans (PGs) are a heterogeneous group of proteins that have anionic GAG side chains such as heparan sulfate and chondroitin/dermatan sulfate covalently bound to core proteins as shown in Fig. 1 . 6) Vessel PGs are involved in the pathogenesis of vascular diseases as well as in the vascular properties of viscoelasticity, permeability, lipid metabolism, homeostasis, thrombosis, and matrix assembly. 7) Vascular endothelial cells express two subclasses of heparan sulfate PGs (HSPGs); one is the high M r subclass which includes a large HSPG perlecan 8) and the other is the low M r subclass which includes the small HSPGs syndecans and glypican. 9) Perlecan is the major product of HSPGs in the cells, 10) and markedly promotes the binding of FGF-2 to its cell surface FGF receptor, although other small HSPGs competitively act on this promotion. 11, 12) Endothelial cells also constitutively synthesize a large chondroitin sulfate PG (CSPG) versican 13) and a small leucine-rich dermatan sulfate PG (DSPG) biglycan. 14) On the other hand, the major types of PGs synthesized by vascular smooth muscle cells are versican, 15, 16) a small DSPG decorin and biglycan 14, 17) with a low expression of perlecan. 8) Epidemiological and experimental evidence suggests that exposure to environmental heavy metals such as lead and cadmium constitutes a risk factor for cardiovascular disease including atherosclerosis (Table 1) . Although there are numerous reports that show cardiovascular lesions induced by heavy metals, the majority of the reports are about the effects of lead and cadmium. Little is known, however, about the mechanisms by which lead and cadmium exhibit vascular toxicity at the cell molecular levels. Our laboratory has investigated the toxic effects of lead and cadmium on the physiological function of vascular cells. The results indicate that these metals induce various functional damages of both vascular endothelial and smooth muscle cells, including the proliferation and the secretion of fibrinolytic proteins. [40] [41] [42] The present report reviews our recent study on the abnormalities of vascular cell functions, including abnormal metabolism of PGs, induced by lead and cadmium.
Toxic Effect of Lead on the Maintenance of Vascular Endothelial Monolayers
The physiological maintenance of endothelial momolayers is important for prevention of atherosclerosis. Lead does not destroy endothelial monolayers 43) but strongly inhibited the repair of deendothelialized areas which had been artificially injured, when the repair was evaluated by morphological observation and the cell numbers appearing in the injured area. 44) It is speculated that lead disturbs the repair of endothelium damaged by hypertensive, environmental, nutritional and other factors. In fact, lead enhanced cadmium-induced a formation of de-endothelialized areas on the monolayers. 43) Since vascular endothelial cell proliferation is one of the most important events in the repair process of damaged endothelium, we next investigated the effect of lead on the proliferation of the cells. 45) The results show that lead markedly reduces the incorporation of [ 3 H]thymidine into the acid-insoluble fraction of growing endothelial cells without nonspecific cell damage; other heavy metals including zinc, copper, manganese and nickel do not exhibit such an inhibition, indicating that lead is a unique metal that inhibits endothelial cell proliferation without nonspecific cell damage. In addition, lead inhibited the proliferation even when the cells were stimulated by exogenous FGF-2. Lead may disturb the repair process in endothelial cell layers which is promoted by FGF-2 leaked from severely damaged or dead cells at the damaged sites.
Mechanism for Lead Inhibition of Vascular Endothelial Cell Proliferation
To address the question whether inhibition of endothelial cell proliferation by lead depends on endogenous FGF-2 or not, we investigated the response of growing endothelial cells to FGF-2 after exposure to lead. 46) In the presence of FGF-2 neutralizing antibody, lead failed to inhibit 3 H]thymidine incorporation by exogenous FGF-2 was markedly reduced when the cells had been pretreated with lead. Taking these results together, it is suggested that the inhibitory effect of lead on endothelial cell proliferation may be due to a lower response of the cells to endogenous FGF-2. When the distribution of endogenous FGF-2 in the cell layer after exposure to lead was examined, the metal significantly reduced the amount of the growth factor bound to the cell surface HSPGs but not that bound to FGF-receptor and accumulated within the When the HSPGs were separated on the basis of their hydrodynamic size by a Sepharose CL-4B column, it was revealed that lead markedly reduced the radioactivity in the high M r subclass rather than the low M r subclass of HSPGs. In addition, Sepharose CL-6B chromatography of the large HSPGs showed that lead does not influence the length of their heparan sulfate chains. Analysis of core proteins labeled with 35 S-labeled amino acids by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis indicated that lead markedly decreased the amount of a large HSPG core protein with a molecular mass of approximately 400 kDa. This core protein was identified as perlecan by Western blot analysis. It is thus suggested that the characteristic change of endothelial PGs after exposure to lead is a decrease in the number of perlecan molecules without a change in length of heparan sulfate chains. These findings suggest, then, that lead does not destroy endothelial cell layers but markedly inhibits the repair of the injured cell layers, which results from a lower response to endogenous FGF-2 18) caused by inhibition of perlecan synthesis in vascular endothelial cells ( Fig. 2; upper panel) .
Effects of Lead on PG Synthesis of Vascular Smooth Muscle Cells
Although endothelial cell perlecan contributes to the physiological maintenance of vascular endothelium through the regulation of FGF-2, other types of PGs, especially CS/DSPGs, accumulate and their composition variously changed in the atherosclerotic vascular wall; vascular smooth muscle cells are the cell type responsible for this accumulation and compositional change. 48, 49) In the vascular wall, low density lipoprotein (LDL) is bound to GAG chains of CS/DSPGs, 50) and the formation of LDL-PG complexes enhanced the accumulation of cholesteryl ester within macrophages present in atherosclerotic regions. 51) According to the response-to-retention hypothesis, the binding and retention of LDL by CS/ DSPGs of vascular smooth muscle cells are believed to be critical in the initiation of atherosclerosis. 52) CS/DSPGs such as versican, biglycan and decorin synthesized and secreted by vascular smooth muscle cells are generally implicated in the development and progression of atherosclerosis, whereas endothelial HSPG perlecan functions as a preventive factor for the disease.
To investigate the effect of lead on the formation of extracellular matrix in the vascular wall, we characterized PGs synthesized by dense cultures of vascular smooth muscle cells after exposure to the metal. 53) Lead significantly decreased the [ 35 S]sulfate incorporation into GAGs accumulated in the cell layer and the conditioned medium, indicating that the synthesis of GAGs is inhibited by the metal in vascular smooth muscle cells as well as endothelial cells. [ 35 S]Sulfate-labeled PGs were separated into three peaks on DEAE-Sephacel chromatography and only the peak with the highest charge density was markedly decreased by lead in both the cell layer and the medium. The highly charged PGs were eluted near the void volume on Sepharose CL-2B molecular sieve chromatography and were sensitive to chondroitin ABC lyase on Sepharose CL-6B chromatography, indicating that lead selectively inhibits the synthesis of large and highly charged CS/DSPGs rather than HSPGs. However, the length of chondroitin sulfate chains of the CS/DSPGs was unaffected by lead. On the other hand, analysis of core proteins labeled with 35 S-labeled amino acids by SDS-polyacrylamide gel electrophoresis showed that lead decreased the amount of a large CS/DSPG with a core protein of approximately 450 kDa; the core protein was identified as CSPG versican core by Lead strongly inhibits the synthesis of perlecan that promotes the binding of endogenous FGF-2 to the receptor in vascular endothelial cells. In vascular smooth muscle cells, lead selectively inhibits the synthesis of versican at a high cell density, whereas cadmium specifically induces that of biglycan and decorin at a low cell density.
Western blot analysis. In addition, lead did not influence the fine structure of the chondroitin sulfate chains when the disaccharide units of the GAG chains were analyzed by fluorophore-assisted carbohydrate electrophoresis.
54) It is therefore suggested that lead inhibits the synthesis of the versican core protein in vascular smooth muscle cells without any change in chondroitin sulfate side chains. As a result, versican-poor extracellular matrix is induced by lead in vascular smooth muscle cells ( Fig. 2;  lower panel) . The effect of lead on the PG synthesis in vascular smooth muscle cells is therefore completely different from that in vascular endothelial cells in which perlecan synthesis is selectively inhibited by the metal. Although the mechanism is unclear, it was clarified that lead disrupts the PG synthesis in vascular cells in a cell-type dependent manner.
Effects of Cadmium on PG Synthesis of Vascular Smooth Muscle Cells
To investigate whether the effect of lead on vascular smooth muscle cell PG synthesis is specific for lead or not, we determined the effect of cadmium on the PG synthesis. 55) Cadmium as well as lead is a possible risk factor for atherosclerosis. Sparse and dense cultures of the cells were metabolically labeled with [ 35 S]sulfate in the presence of cadmium at noncytotoxic levels. It was found that cadmium significantly decreased the incorporation of [ ]Sulfate-labeled PGs were separated into three peaks on DEAE-Sephacel chromatography, and the middle peak between low and highly charged PG peaks was markedly increased by cadmium in the cell layers of sparse vascular smooth muscle cells; however, no alteration was observed in dense cultures. Sepharose CL-4B molecular sieve chromatography and Sepharose CL-6B chromatography showed that the cadmium-induced PGs was small CS/DSPGs, and the hydrodynamic size and the length of the chondroitin/dermatan sulfate chains in the PGs were not changed by the metal. In addition, fluorophore-assisted carbohydrate electrophoresis analysis showed that cadmium did not change the sulfation pattern of disaccharides in chondroitin/ dermatan sulfate chains. 54) The small CS/DSPGs were identified as biglycan and decorin by Western blot analysis. Furthermore, it was shown that cadmium raised the level of decorin core mRNA but not that of biglycan core mRNA when analyzed by reverse transcription polymerase chain reaction, suggesting that the metal stimulates the synthesis of biglycan and decorin at the post-transcriptional level including stabilization of the mRNA, and transcriptional level, respectively. However, cadmium decreased other cell layer-associated PGs that were separated from biglycan and decorin by DEAESephacel chromatography in the sparse cells; as a result, the overall amount of GAGs was decreased in both the cell layer and the conditioned medium. It is thus suggested that low levels of cadmium increase DSPGs, biglycan and decorin without any change in structure of dermatan sulfate chains in the extracellular matrix of vascular smooth muscle cells only when the cell density is low, whereas other cell layer-associated PGs, such as versican, were decreased by the metal ( Fig. 2; lower panel) . Although it is not certain whether lead and cadmium directly induce atherosclerosis in human vessels, these metals may be involved in the progression and formation of the vascular lesion through change in the composition of extracellular matrix, which includes PGs derived from vascular smooth muscle cells in the intima of vascular walls in different manners.
CONCLUSION
Regulation of PG synthesis is different between physiological and pathological conditions, and depends on the cell type and the cell density. Our results demonstrate that lead inhibits the repair of the injured cell layers, which results from a lower response to endogenous FGF-2 caused by inhibition of perlecan synthesis in vascular endothelial cells. They also show that lead selectively inhibits the synthesis of versican in vascular smooth muscle cells at a high cell density, whereas cadmium specifically induces that of biglycan and decorin at a low cell density. These observations reveal the effects of heavy metals on PG synthesis to be specific for each of them as well as cell-type and cell-density dependent. We propose that the pathogenesis of lead-and cadmium-induced atherosclerosis involves the abnormal PG metabolism in vascular cells. Abnormal metabolism of extracellular matrix in vascular cells by lead and cadmium is considered to be helpful for understanding the toxic effects of heavy metals in not only vascular tissue but also other tissues that are the targets of heavy metals.
